Harvard Bioscience Inc
HBIONasdaqCIK 1123494TechnologyFiscal year ends Dec 31
Reports and events: 280 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2026-08-1116:30 ET | 10-Q | Quarterly reportPeriod 2026-06-30 | 0001171843-26-005425 |
| 2026-08-1107:00 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-005406 |
| 2026-08-1107:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-005405 |
| 2026-06-0216:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-26-003877 |
| 2026-05-1216:30 ET | 10-Q | Quarterly reportPeriod 2026-03-31 | 0001171843-26-003311 |
| 2026-05-1207:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-003271 |
| 2026-05-1207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-003270 |
| 2026-04-2116:56 ET | DEF 14A | Proxy statementPeriod 2026-06-02 | 0001171843-26-002617 |
| 2026-03-2308:00 ET | SCHEDULE 13D | Ownership report, active investor | 0001171843-26-001839 |
| 2026-03-1707:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-001614 |
| 2026-03-1308:20 ET | 10-K | Annual reportPeriod 2025-12-31 | 0001171843-26-001548 |
| 2026-03-1207:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-001504 |
| 2026-03-1007:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-26-001447 |
| 2026-03-0616:01 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-26-001384 |
| 2026-02-1007:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-26-000721 |
| 2026-01-3017:15 ET | DEF 14A | Proxy statementPeriod 2026-03-06 | 0001171843-26-000541 |
| 2026-01-2916:30 ET | 8-K | 2.05 Exit or disposal costs; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000516 |
| 2026-01-2016:01 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001171843-26-000343 |
| 2026-01-1207:30 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-26-000203 |
| 2025-12-1707:30 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-007972 |
| 2025-12-0516:30 ET | 8-K | 8.01 Other events | 0001171843-25-007776 |
| 2025-11-0616:31 ET | 10-Q | Quarterly reportPeriod 2025-09-30 | 0001171843-25-007099 |
| 2025-11-0607:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-007071 |
| 2025-10-0308:01 ET | 8-K | 3.01 Delisting notice | 0001171843-25-006260 |
| 2025-09-0907:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001171843-25-005787 |
| 2025-08-1316:30 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-005377 |
| 2025-08-1116:30 ET | 10-Q | Quarterly reportPeriod 2025-06-30 | 0001171843-25-005287 |
| 2025-08-1116:30 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001171843-25-005288 |
| 2025-08-1107:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-005262 |
| 2025-07-1707:01 ET | 8-K | 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-004508 |
| 2025-06-2716:45 ET | 8-K/A | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001171843-25-004196 |
| 2025-06-2316:46 ET | 8-K | 3.01 Delisting notice; 9.01 Financial statements and exhibits | 0001171843-25-004036 |
| 2025-06-1316:45 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-003882 |
| 2025-06-0217:00 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001171843-25-003574 |
| 2025-05-1216:46 ET | 10-Q | Quarterly reportPeriod 2025-03-31 | 0001171843-25-003093 |
| 2025-05-1207:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-003044 |
| 2025-04-2116:45 ET | DEF 14A | Proxy statementPeriod 2025-06-02 | 0001171843-25-002341 |
| 2025-04-1616:46 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001171843-25-002238 |
| 2025-04-1016:46 ET | 8-K | 3.01 Delisting notice; 5.02 Departure or appointment of officers or directors; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-002149 |
| 2025-03-1419:51 ET | 10-K | Annual reportPeriod 2024-12-31 | 0001171843-25-001472 |
| 2025-03-1207:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-25-001422 |
| 2025-03-1220:01 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001171843-25-001416 |
| 2024-11-0816:45 ET | 10-Q | Quarterly reportPeriod 2024-09-30 | 0001171843-24-006181 |
| 2024-11-0707:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-006086 |
| 2024-08-0809:00 ET | 10-Q | Quarterly reportPeriod 2024-06-30 | 0001171843-24-004564 |
| 2024-08-0808:29 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-004562 |
| 2024-05-1417:20 ET | 8-K | 5.07 Shareholder vote results | 0001171843-24-002878 |
| 2024-05-0717:00 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001171843-24-002618 |
| 2024-05-0707:00 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-24-002591 |
| 2024-04-0316:45 ET | DEF 14A | Proxy statementPeriod 2024-05-14 | 0001171843-24-001813 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 24, 2026, 15:05 ET. Listed shows no prices and gives no investment advice.